IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avanir Pharmaceuticals Inc

CUSIP: 05348P40 | 3 institutional holders

Quarters

Q4 2014Q3 2014Q2 2014Q1 2014Q4 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2014

Ingalls & Snyder LLC758,055
0.7% of portfolio›$12.8K
StyleTurnoverLocationFiled
Ingalls & Snyder LLC
758,055$12.8K0.7%CoreVery LowNew York, NY2015-01-28